| Primary |
| Haemorrhage |
16.7% |
| Caesarean Section |
9.5% |
| Postpartum Haemorrhage |
7.6% |
| Anaesthesia |
7.1% |
| Uterine Haemorrhage |
7.1% |
| Menorrhagia |
6.7% |
| Metrorrhagia |
6.2% |
| Product Used For Unknown Indication |
6.2% |
| Abortion |
5.2% |
| Uterine Atony |
5.2% |
| Vaginal Haemorrhage |
3.8% |
| Abortion Induced |
2.9% |
| Accidental Exposure |
2.4% |
| Hypertension |
2.4% |
| Menstrual Disorder |
2.4% |
| Abortion Threatened |
1.9% |
| Contraception |
1.9% |
| Uterine Leiomyoma |
1.9% |
| Lochial Infection |
1.4% |
| Pain |
1.4% |
|
| Wrong Drug Administered |
21.3% |
| Haemorrhage |
7.7% |
| Vomiting |
7.7% |
| Accidental Exposure |
7.1% |
| Accidental Drug Intake By Child |
5.9% |
| Disseminated Intravascular Coagulation |
5.3% |
| Vaginal Haemorrhage |
4.7% |
| Uterine Haemorrhage |
4.1% |
| Agitation |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Malaise |
3.6% |
| Tremor |
3.6% |
| Ventricular Hypokinesia |
3.6% |
| Paraesthesia |
3.0% |
| Tachycardia |
3.0% |
| Vision Blurred |
3.0% |
| Appetite Disorder |
2.4% |
| Dizziness |
2.4% |
| Intentional Drug Misuse |
2.4% |
| Nervousness |
2.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
36.0% |
| Foetal Exposure During Pregnancy |
10.6% |
| Product Used For Unknown Indication |
10.0% |
| Caesarean Section |
9.3% |
| Anaesthesia |
7.1% |
| Haemorrhage |
6.4% |
| Postpartum Haemorrhage |
5.1% |
| Headache |
2.6% |
| Migraine |
1.9% |
| Menorrhagia |
1.6% |
| Asthma |
1.3% |
| Hypertension |
1.3% |
| Uterine Haemorrhage |
1.3% |
| Lochial Infection |
1.0% |
| Uterine Atony |
1.0% |
| Uterine Leiomyoma |
1.0% |
| Amniocentesis Abnormal |
0.6% |
| Cervix Dystocia |
0.6% |
| Contraception |
0.6% |
| Cough |
0.6% |
|
| Disseminated Intravascular Coagulation |
30.7% |
| Treatment Noncompliance |
10.7% |
| Hypertension |
5.3% |
| Postpartum Haemorrhage |
5.3% |
| Premature Separation Of Placenta |
5.3% |
| Completed Suicide |
4.0% |
| Paraesthesia |
4.0% |
| Uterine Atony |
4.0% |
| Vomiting |
4.0% |
| Agitation |
2.7% |
| Drug Hypersensitivity |
2.7% |
| Malaise |
2.7% |
| Neonatal Tachypnoea |
2.7% |
| Tibial Torsion |
2.7% |
| Trismus |
2.7% |
| Weight Decreased |
2.7% |
| Wound Secretion |
2.7% |
| Yellow Skin |
2.7% |
| Agranulocytosis |
1.3% |
| Confusional State |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.6% |
| Antiretroviral Therapy |
5.8% |
| Uterine Contractions Abnormal |
5.8% |
| Hiv Infection |
5.6% |
| Headache |
4.9% |
| Contraception |
4.4% |
| Pain |
3.9% |
| Depression |
3.6% |
| Cystitis |
3.4% |
| Migraine |
3.4% |
| Anxiety |
2.9% |
| Hypertension |
2.9% |
| Epidural Anaesthesia |
2.2% |
| Antacid Therapy |
1.9% |
| Caesarean Section |
1.9% |
| Laxative Supportive Care |
1.9% |
| Premedication |
1.9% |
| Drug Use For Unknown Indication |
1.7% |
| Sleep Disorder |
1.7% |
| Pulmonary Embolism |
1.5% |
|
| Vomiting |
17.3% |
| Drug Withdrawal Syndrome Neonatal |
7.4% |
| Pulmonary Embolism |
7.4% |
| Enterocolitis Haemorrhagic |
6.2% |
| Anaphylactic Shock |
4.9% |
| Drug Exposure During Pregnancy |
4.9% |
| Laryngeal Oedema |
4.9% |
| Pregnancy |
4.9% |
| Uterine Atony |
4.9% |
| Uterine Hypotonus |
4.9% |
| Cholelithiasis |
3.7% |
| Pain |
3.7% |
| Paraesthesia |
3.7% |
| Postpartum Haemorrhage |
3.7% |
| Premature Rupture Of Membranes |
3.7% |
| Uterine Disorder |
3.7% |
| Cholecystitis Chronic |
2.5% |
| Depression |
2.5% |
| Drug Dose Omission |
2.5% |
| Metrorrhagia |
2.5% |
|
| Interacting |
| Intra-uterine Death |
50.0% |
| Labour Induction |
50.0% |
|
| Kidney Transplant Rejection |
100.0% |
|
